 Acumen measures the immediate output and considers it when looking for businesses to invest in.It doesn't go further in investigating whether these social changes is contributing to decrease in malaria or improvement in health and environment.Its former CEO, Brian Trelstad argues that the latter approach is complicated, expensive and impractical for emerging companies.